These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 27548441)

  • 21. An update of treatments of hepatocellular carcinoma in patients refractory to sorafenib.
    Ielasi L; Sansone V; Granito A; Benevento F; De Lorenzo S; Tovoli F
    Drugs Today (Barc); 2018 Oct; 54(10):615-627. PubMed ID: 30398482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An updated meta-analysis of randomized controlled trials assessing the effect of sorafenib in advanced hepatocellular carcinoma.
    Peng S; Zhao Y; Xu F; Jia C; Xu Y; Dai C
    PLoS One; 2014; 9(12):e112530. PubMed ID: 25460347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lenvatinib: a potential breakthrough in advanced hepatocellular carcinoma?
    Oikonomopoulos G; Aravind P; Sarker D
    Future Oncol; 2016 Feb; 12(4):465-76. PubMed ID: 26785762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Next Generation of Preclinical Liver Cancer Models.
    Weber A; O'Connor T; Heikenwalder M
    Clin Cancer Res; 2015 Oct; 21(19):4254-6. PubMed ID: 26169964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial.
    Bruix J; Raoul JL; Sherman M; Mazzaferro V; Bolondi L; Craxi A; Galle PR; Santoro A; Beaugrand M; Sangiovanni A; Porta C; Gerken G; Marrero JA; Nadel A; Shan M; Moscovici M; Voliotis D; Llovet JM
    J Hepatol; 2012 Oct; 57(4):821-9. PubMed ID: 22727733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy.
    Park JG
    Clin Mol Hepatol; 2015 Sep; 21(3):287-94. PubMed ID: 26527250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MEK 1/2 inhibitors in the treatment of hepatocellular carcinoma.
    Facciorusso A; Licinio R; Carr BI; Di Leo A; Barone M
    Expert Rev Gastroenterol Hepatol; 2015 Jul; 9(7):993-1003. PubMed ID: 25915713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is the efficacy of sorafenib treatment in patients with hepatocellular carcinoma affected by age?
    Cabibbo G; Maida M; Cammà C; Craxì A
    Expert Rev Anticancer Ther; 2013 Dec; 13(12):1355-61. PubMed ID: 24224926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Mechanism and Prediction of Sorafenib Chemoresistance in Human Hepatocellular Carcinoma.
    Nishida N; Kitano M; Sakurai T; Kudo M
    Dig Dis; 2015 Oct; 33(6):771-9. PubMed ID: 26488287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Network features suggest new hepatocellular carcinoma treatment strategies.
    Lavi O; Skinner J; Gottesman MM
    BMC Syst Biol; 2014 Jul; 8():88. PubMed ID: 25070212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New molecular therapies for hepatocellular carcinoma.
    Torrecilla S; Llovet JM
    Clin Res Hepatol Gastroenterol; 2015 Sep; 39 Suppl 1():S80-5. PubMed ID: 26206572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment efficacy differences of sorafenib for advanced hepatocellular carcinoma: a meta-analysis of randomized clinical trials.
    Shao YY; Shau WY; Chan SY; Lu LC; Hsu CH; Cheng AL
    Oncology; 2015; 88(6):345-52. PubMed ID: 25572912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma.
    Liu Z; Lin Y; Zhang J; Zhang Y; Li Y; Liu Z; Li Q; Luo M; Liang R; Ye J
    J Exp Clin Cancer Res; 2019 Nov; 38(1):447. PubMed ID: 31684985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of sorafenib in hepatocellular carcinoma.
    Gholam P
    Clin Adv Hematol Oncol; 2015 Apr; 13(4):232-4. PubMed ID: 26352581
    [No Abstract]   [Full Text] [Related]  

  • 35. Current status and future prospects of chemotherapy for advanced hepatocellular carcinoma.
    Moriguchi M; Umemura A; Itoh Y
    Clin J Gastroenterol; 2016 Aug; 9(4):184-90. PubMed ID: 27401471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcomes of patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective study of routine clinical practice in multi-institutions.
    Lee SH; Song IH; Noh R; Kang HY; Kim SB; Ko SY; Lee ES; Kim SH; Lee BS; Kim AN; Chae HB; Kim HS; Lee TH; Kang YW; Lee JD; Lee HY
    BMC Cancer; 2015 Apr; 15():236. PubMed ID: 25885683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treating advanced hepatocellular carcinoma: How to get out of first gear.
    Harding JJ; Abou-Alfa GK
    Cancer; 2014 Oct; 120(20):3122-30. PubMed ID: 24898783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of everolimus on survival in advanced hepatocellular carcinoma after failure of sorafenib: the EVOLVE-1 randomized clinical trial.
    Zhu AX; Kudo M; Assenat E; Cattan S; Kang YK; Lim HY; Poon RT; Blanc JF; Vogel A; Chen CL; Dorval E; Peck-Radosavljevic M; Santoro A; Daniele B; Furuse J; Jappe A; Perraud K; Anak O; Sellami DB; Chen LT
    JAMA; 2014 Jul; 312(1):57-67. PubMed ID: 25058218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial.
    Zhu AX; Park JO; Ryoo BY; Yen CJ; Poon R; Pastorelli D; Blanc JF; Chung HC; Baron AD; Pfiffer TE; Okusaka T; Kubackova K; Trojan J; Sastre J; Chau I; Chang SC; Abada PB; Yang L; Schwartz JD; Kudo M;
    Lancet Oncol; 2015 Jul; 16(7):859-70. PubMed ID: 26095784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic Treatment of Patients with Advanced, Unresectable Hepatocellular Carcinoma: Emergence of Therapies.
    Sun W; Cabrera R
    J Gastrointest Cancer; 2018 Jun; 49(2):107-115. PubMed ID: 29453759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.